Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering a funding opportunity for the Nonhuman Primate Reagent Resource (NHPRR) through a cooperative agreement aimed at enhancing research capabilities in nonhuman primate (NHP) models. Applicants are required to propose the development of at least two new immunologic reagents—one for in vitro and one for in vivo use—that are either not commercially available or not optimized for NHP research, emphasizing the critical role of NHPs in preclinical studies for immune-mediated diseases. The initiative supports the production and distribution of these reagents, alongside management and community engagement activities, with a maximum project period of five years and an anticipated funding amount of $1.3 million for FY 2026. Interested applicants must submit their proposals by October 28, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
Eligible Applicants
Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.